Alan Ashworth

Molecular Biology · 2000–2020

A researcher in the Science corpus: 23 papers; trusts 13 researchers and is trusted by 20 researchers here, as inferred from the citation graph.

Subfields

Whom Alan Ashworth trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Jan H. J. Hoeijmakers
  2. M. Moynahan
  3. N. Turner
  4. W. Kaelin
  5. C. Lord
  6. M. Jasin
  7. Andrew Tutt
  8. S. West
  9. Michael Weller
  10. K. Rothkamm

Who trusts Alan Ashworth overall

  1. A. Mendes-Pereira
  2. Mark J. O'Connor
  3. C. Lord
  4. D. Jelovac
  5. S. Martin
  6. Yves Pommier
  7. Lisa A. Carey
  8. Jan H. J. Hoeijmakers
  9. D. Fruman
  10. R. Brough

Papers from Alan Ashworth's perspective

Ordered by how strongly the researchers Alan Ashworth trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy (Nature)
  2. Sister chromatid gene conversion is a prominent double‐strand break repair pathway in mammalian cells (EMBO Journal)
  3. Biallelic Inactivation of BRCA2 in Fanconi Anemia (Science)
  4. The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin*
  5. BRCA2 is required for homology-directed repair of chromosomal breaks. (Molecules and Cells)
  6. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (Clinical Cancer Research)
  7. Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors (EMBO Molecular Medicine)
  8. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair (Nature Cell Biology)
  9. Repeated observation of breast tumor subtypes in independent gene expression data sets (Proceedings of the National Academy of Sciences of the United States of America)
  10. Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM (Cancer Research)

Their papers